APA (7th ed.) Citation

KM, K., K, L., NJ, T., ME, M., BM, W., EN, G., . . . DW, K. (2026). Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization. PLoS pathogens, 22(2), e1013905. https://doi.org/10.1371/journal.ppat.1013905

Chicago Style (17th ed.) Citation

KM, Konrath, et al. "Immune-focused RBD Nanoparticles Induce Cross-reactive, RBS-directed Responses Capable of Variant-resistant SARS-CoV-2 Neutralization." PLoS Pathogens 22, no. 2 (2026): e1013905. https://doi.org/10.1371/journal.ppat.1013905.

MLA (9th ed.) Citation

KM, Konrath, et al. "Immune-focused RBD Nanoparticles Induce Cross-reactive, RBS-directed Responses Capable of Variant-resistant SARS-CoV-2 Neutralization." PLoS Pathogens, vol. 22, no. 2, 2026, p. e1013905, https://doi.org/10.1371/journal.ppat.1013905.